Does any site consent patients for medications derived from blood products (e.g., IVIG, Kcentra) to cover for the risk that the med may carry a risk of transmitting infectious agents, e.g., viruses. There is also the possibility that unknown infectious agents may be present in such products.
Appreciate your feedback.
Renu Bajwa, PharmD